Preoperative Brain MRI for Clinical Stage IA Lung Cancer: is Routine Scanning Rational?

Overview

Journal J Cancer Res Clin Oncol

Specialty Oncology

Date 2018 Dec 12

PMID 30536037

Citations 5

Authors

Lingdun Zhuge

Yangle Huang

Shengfei Wang

Juntao Xie

Binhao Huang

Difan Zheng

Shanbo Zheng

Yue Zhao

Hengyu Mao

David O Wilson

James D Luketich

Jiaqing Xiang

Haiquan Chen

Jie Zhang

Affiliations

Soon will be listed here.

Abstract

Purpose: Early detection and control of lung cancer brain metastases (BMs) are important. However, several guideline recommendations are inconsistent with regard to routine preoperative brain MRI, especially in patients with clinical stage IA lung cancer. Our study evaluated the value of preoperative brain MRI in patients with clinical stage IA lung cancer.

Methods: A retrospective analysis of patients with lung cancer was performed using a prospectively collected database. Clinical data and the results of brain MRI were collected and analyzed.

Results: Patients with pathologically proved primary lung cancer who underwent an MRI at initial diagnosis were identified (3392 patients). In total, 170 patients (5.0%) were diagnosed with BMs. The increased frequency of BMs was significantly associated with advanced clinical stage (P = 0.000) and pathological type (P = 0.011). BMs were detected in 11 out of 1595 patients with clinical stage IA lung cancer (0.7%). BMs were more common in patients with clinical stage cT1c lung cancer (1.9%) than those with clinical stage cT1a or cT1b (0.1%, odds ratio = 21.30, 95% confidence interval: 2.7-166.9, P = 0.000). All patients with stage IA lung cancer and BMs had solid lung lesions (P = 0.002).

Conclusions: Preoperative brain MRI might help identify BMs in patients with lung cancer that has progressed beyond stage IA. In patients with clinical stage IA lung cancer, we do not recommend preoperative brain MRI, but it may potentially be beneficial in those with solid T1c cancers.

Citing Articles

Brain Imaging in Patients with Non-Small Cell Lung Cancer-A Systematic Review.

Mayer N, Boschetti L, Scarci M, Cioffi U, De Simone M, Schnider M J Clin Med. 2025; 14(3).

PMID: 39941379 PMC: 11818832. DOI: 10.3390/jcm14030708.

A systematic review of brain metastases from lung cancer using magnetic resonance neuroimaging: Clinical and technical aspects.

Ghaderi S, Mohammadi S, Mohammadi M, Najafi Asli Pashaki Z, Heidari M, Khatyal R J Med Radiat Sci. 2024; 71(2):269-289.

PMID: 38234262 PMC: 11177032. DOI: 10.1002/jmrs.756.

Clinical features and molecular genetics associated with brain metastasis in suspected early-stage non-small cell lung cancer.

Kim K, Lee J, Lee J, Yong S, Kim E, Jung J Front Oncol. 2023; 13:1148475.

PMID: 37139160 PMC: 10150586. DOI: 10.3389/fonc.2023.1148475.

Is extrathoracic metastasis screening necessary for clinical stage IA non-small cell lung cancer?.

Iijima Y, Ishikawa M, Iwai S, Motono N, Yamagishi S, Koizumi K Sci Prog. 2022; 105(1):368504221085152.

PMID: 35275504 PMC: 10358501. DOI: 10.1177/00368504221085152.

Magnetic Resonance Imaging Segmentation on the Basis of Boundary Tracking Algorithm in Lung Cancer Surgery.

Liu C, Ye F, Hu Y, Gao S, Lu Y, Guo Y Contrast Media Mol Imaging. 2021; 2021:1368687.

PMID: 34858112 PMC: 8592752. DOI: 10.1155/2021/1368687.

References

Tanaka K, Kubota K, Kodama T, Nagai K, Nishiwaki Y . Extrathoracic staging is not necessary for non-small-cell lung cancer with clinical stage T1-2 N0. Ann Thorac Surg. 1999; 68(3):1039-42. DOI: 10.1016/s0003-4975(99)00694-3. View

Penel N, Brichet A, Prevost B, Duhamel A, Assaker R, Dubois F . Pronostic factors of synchronous brain metastases from lung cancer. Lung Cancer. 2001; 33(2-3):143-54. DOI: 10.1016/s0169-5002(01)00202-1. View

Schouten L, Rutten J, Huveneers H, Twijnstra A . Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer. 2002; 94(10):2698-705. DOI: 10.1002/cncr.10541. View

Kim S, Kim J, Park H, Cho M, Kim J, Kim J . Screening of brain metastasis with limited magnetic resonance imaging (MRI): clinical implications of using limited brain MRI during initial staging for non-small cell lung cancer patients. J Korean Med Sci. 2005; 20(1):121-6. PMC: 2808557. DOI: 10.3346/jkms.2005.20.1.121. View

Ampil F, Caldito G, Milligan S, Mills G, Nanda A . The elderly with synchronous non-small cell lung cancer and solitary brain metastasis: does palliative thoracic radiotherapy have a useful role?. Lung Cancer. 2007; 57(1):60-5. DOI: 10.1016/j.lungcan.2007.02.006. View

Park H, Kim Y, Kim H, Koh W, Suh G, Chung M . Routine screening by brain magnetic resonance imaging decreased the brain metastasis rate following surgery for lung adenocarcinoma. Lung Cancer. 2007; 58(1):68-72. DOI: 10.1016/j.lungcan.2007.04.010. View

Nguyen T, DeAngelis L . Brain metastases. Neurol Clin. 2007; 25(4):1173-92, x-xi. DOI: 10.1016/j.ncl.2007.07.011. View

Jena A, Taneja S, Talwar V, Sharma J . Magnetic resonance (MR) patterns of brain metastasis in lung cancer patients: correlation of imaging findings with symptom. J Thorac Oncol. 2008; 3(2):140-4. DOI: 10.1097/JTO.0b013e318161d775. View

De Cos J, Sojo Gonzalez M, Montero M, Perez Calvo M, Vicente M, Hernandez Valle M . Non-small cell lung cancer and silent brain metastasis. Survival and prognostic factors. Lung Cancer. 2008; 63(1):140-5. DOI: 10.1016/j.lungcan.2008.04.013. View

10.

Na I, Lee T, Choe D, Cheon G, Kim C, Koh J . A diagnostic model to detect silent brain metastases in patients with non-small cell lung cancer. Eur J Cancer. 2008; 44(16):2411-7. DOI: 10.1016/j.ejca.2008.07.003. View

11.

Fischer B, Lassen U, Mortensen J, Larsen S, Loft A, Bertelsen A . Preoperative staging of lung cancer with combined PET-CT. N Engl J Med. 2009; 361(1):32-9. DOI: 10.1056/NEJMoa0900043. View

12.

Hubbs J, Boyd J, Hollis D, Chino J, Saynak M, Kelsey C . Factors associated with the development of brain metastases: analysis of 975 patients with early stage nonsmall cell lung cancer. Cancer. 2010; 116(21):5038-46. DOI: 10.1002/cncr.25254. View

13.

Lim E, Baldwin D, Beckles M, Duffy J, Entwisle J, Faivre-Finn C . Guidelines on the radical management of patients with lung cancer. Thorax. 2010; 65 Suppl 3:iii1-27. DOI: 10.1136/thx.2010.145938. View

14.

Baldwin D, White B, Schmidt-Hansen M, Champion A, Melder A . Diagnosis and treatment of lung cancer: summary of updated NICE guidance. BMJ. 2011; 342:d2110. DOI: 10.1136/bmj.d2110. View

15.

Nelson J, Allen L, Parker L, Hayward M, Zhao N, Hayes D . Early brain recurrences are potentially detectable in asymptomatic, early stage lung adenocarcinoma. Clin Oncol (R Coll Radiol). 2011; 23(10):718-20. DOI: 10.1016/j.clon.2011.09.002. View

16.

Horinouchi H, Sekine I, Sumi M, Ito Y, Nokihara H, Yamamoto N . Brain metastases after definitive concurrent chemoradiotherapy in patients with stage III lung adenocarcinoma: carcinoembryonic antigen as a potential predictive factor. Cancer Sci. 2012; 103(4):756-9. PMC: 7659305. DOI: 10.1111/j.1349-7006.2012.02217.x. View

17.

Silvestri G, Gonzalez A, Jantz M, Margolis M, Gould M, Tanoue L . Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143(5 Suppl):e211S-e250S. DOI: 10.1378/chest.12-2355. View

18.

Siegel R, Ma J, Zou Z, Jemal A . Cancer statistics, 2014. CA Cancer J Clin. 2014; 64(1):9-29. DOI: 10.3322/caac.21208. View

19.

Villano J, Durbin E, Normandeau C, Thakkar J, Moirangthem V, Davis F . Incidence of brain metastasis at initial presentation of lung cancer. Neuro Oncol. 2014; 17(1):122-8. PMC: 4483041. DOI: 10.1093/neuonc/nou099. View

20.

ODowd E, Kumaran M, Anwar S, Palomo B, Baldwin D . Brain metastases following radical surgical treatment of non-small cell lung cancer: is preoperative brain imaging important?. Lung Cancer. 2014; 86(2):185-9. DOI: 10.1016/j.lungcan.2014.08.021. View